摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aS,4S,6aR)-4-(hex-5-yn-1-yl)tetrahydrothieno[3,4-d]imidazol-2-one | 1373128-13-2

中文名称
——
中文别名
——
英文名称
(3aS,4S,6aR)-4-(hex-5-yn-1-yl)tetrahydrothieno[3,4-d]imidazol-2-one
英文别名
(3aS,4S,6aR)-4-(hex-5-yn-1-yl)tetrahydro-thieno[3,4-d]imidazole-2-one;(3as,4s,6ar)-4-(Hex-5-Yn-1-Yl)tetrahydro-1h-Thieno[3,4-D]imidazol-2(3h)-One;(3aS,4S,6aR)-4-hex-5-ynyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one
(3aS,4S,6aR)-4-(hex-5-yn-1-yl)tetrahydrothieno[3,4-d]imidazol-2-one化学式
CAS
1373128-13-2
化学式
C11H16N2OS
mdl
——
分子量
224.327
InChiKey
MGFIEEWTLUFGHD-GUBZILKMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    452.6±30.0 °C(Predicted)
  • 密度:
    1.130±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    15
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.73
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (3aS,4S,6aR)-4-(hex-5-yn-1-yl)tetrahydrothieno[3,4-d]imidazol-2-onesodium ascorbate 、 sodium hydroxide 、 三[(1-苄基-1H-1,2,3-三唑-4-基)甲基]胺 作用下, 以 叔丁醇 为溶剂, 反应 55.5h, 生成 2-[4-[2-[2-[2-[2-[2-[4-[4-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]butyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
    参考文献:
    名称:
    Triazole biotin: a tight-binding biotinidase-resistant conjugate
    摘要:
    通过炔基生物素衍生物的 CuAAC 反应,所有生物素化蛋白质中的天然酰胺键都被三唑取代。结果表明,三唑连接的加合物对无处不在的水解酶生物素酶具有很强的抗性,并能以低 pM 范围的解离常数与阿维丁结合。实验证明,这种策略可用于生产一系列抗生物素酶的生物素-Gd-DOTA 造影剂。
    DOI:
    10.1039/c3ob41837e
  • 作为产物:
    参考文献:
    名称:
    Triazole biotin: a tight-binding biotinidase-resistant conjugate
    摘要:
    通过炔基生物素衍生物的 CuAAC 反应,所有生物素化蛋白质中的天然酰胺键都被三唑取代。结果表明,三唑连接的加合物对无处不在的水解酶生物素酶具有很强的抗性,并能以低 pM 范围的解离常数与阿维丁结合。实验证明,这种策略可用于生产一系列抗生物素酶的生物素-Gd-DOTA 造影剂。
    DOI:
    10.1039/c3ob41837e
点击查看最新优质反应信息

文献信息

  • Biotin Analogues with Antibacterial Activity Are Potent Inhibitors of Biotin Protein Ligase
    作者:Tatiana P. Soares da Costa、William Tieu、Min Y. Yap、Ondrej Zvarec、Jan M. Bell、John D. Turnidge、John C. Wallace、Grant W. Booker、Matthew C. J. Wilce、Andrew D. Abell、Steven W. Polyak
    DOI:10.1021/ml300106p
    日期:2012.6.14
    bacteria, such as clinically important Staphylococcus aureus. The essential multifunctional enzyme, biotin protein ligase (BPL), is one potential drug target for new antibiotics. We report the synthesis and characterization of a series of biotin analogues with activity against BPLs from S. aureus, Escherichia coli, and Homo sapiens. Two potent inhibitors with K i < 100 nM were identified with antibacterial
    迫切需要开发新的抗生素来抵抗耐药细菌的繁殖,例如临床上重要的金黄色葡萄球菌。基本的多功能酶生物素蛋白连接酶(BPL)是新抗生素的潜在药物靶标之一。我们报告了一系列生物素类似物的合成和表征,这些生物素类似物具有针对来自金黄色葡萄球菌,大肠杆菌和智人的BPL的活性。鉴定出K i <100 nM的两种有效抑制剂对一组金黄色葡萄球菌临床分离株具有抗菌活性(MIC 2-16杯/ mL)。鉴定并表征了具有高配体效率和同工酶之间选择性> 20倍的化合物。抗菌作用方式显示为通过抑制BPL。BPL和抑制剂之间的双分子相互作用是通过表面等离振子共振研究和X射线晶体学确定的。这些发现为具有更高效力和选择性的第二代抑制剂和抗生素铺平了道路。
  • [EN] BIOTINIDASE RESISTANT BIOTINYL COMPOUNDS<br/>[FR] COMPOSÉS DE BIOTINYLE RÉSISTANT À LA BIOTINIDASE
    申请人:UNIV EDINBURGH
    公开号:WO2013144604A1
    公开(公告)日:2013-10-03
    Disclosed are biotinidase resistant biotinyl-conjugates, and uses thereof. The conjugates comprise a biotinyl moiety coupled to a therapeutic or diagnostic moiety by a triazole group. The conjugates have applications as diagnostic or therapeutic agents, in methods of diagnosis or treatment of a subject, for example as MRI contrast agents in MRI imaging of a subject. In particular, biotinyl-chelate complexes find utility in two and three step pretargeting strategies and have high affinity for avidin, streptavidin and related proteins. Also disclosed are biotinylating agents and kits, and the use of compounds for biotinylation, including for the synthesis of biotinyl-chelate complexes and biotinyl-conjugates.
    本发明涉及耐生物素酶的生物素基共轭物及其用途。该共轭物包括通过三唑基团将生物素基团与治疗或诊断基团耦合而成。该共轭物可用于诊断或治疗剂,用于诊断或治疗主体的方法,例如用于主体的MRI成像中作为MRI对比剂。特别是,生物素基螯合物复合物在两步或三步预靶向策略中具有实用性,并具有高亲和力,可与亲合素、链霉亲合素和相关蛋白结合。本发明还涉及生物素化试剂和试剂盒,以及用于生物素化的化合物的使用,包括用于合成生物素基螯合物复合物和生物素基共轭物的化合物。
  • CITU: A Peptide and Decarboxylative Coupling Reagent
    作者:Justine N. deGruyter、Lara R. Malins、Laurin Wimmer、Khalyd J. Clay、Javier Lopez-Ogalla、Tian Qin、Josep Cornella、Zhiqing Liu、Guanda Che、Denghui Bao、Jason M. Stevens、Jennifer X. Qiao、Martin P. Allen、Michael A. Poss、Phil S. Baran
    DOI:10.1021/acs.orglett.7b03121
    日期:2017.11.17
    Tetrachloro-N-hydroxyphthalimide tetramethyluronium hexafluorophosphate (CITU) is disclosed as a convenient and economical reagent for both acylation and decarboxylative cross-coupling chemistries. Within the former set of reactions, CITU displays reactivity similar to that of common coupling reagents, but with increased safety and reduced cost. Within the latter, increased yields, more rapid conversion, and a
    四Ç hloro- Ñ -hydroxyphthal我酰胺吨etramethyl ù ronium六氟磷酸盐(CITU)中公开了作为用于既酰化和脱羧交叉偶联化学方便和经济的试剂。在前一组反应中,CITU显示出与普通偶联剂相似的反应性,但具有更高的安全性并降低了成本。在后者中,在一系列报道的脱羧转化中,可能增加产率,更快地转化和简化程序。
  • [EN] NOVEL ANTIMICROBIAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS ANTIMICROBIENS
    申请人:ADELAIDE RES & INNOVATION PTY
    公开号:WO2013040647A1
    公开(公告)日:2013-03-28
    A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.
    披萨店的招牌菜是各种口味的披萨,包括经典的意大利香肠披萨、夏威夷披萨、墨西哥辣椒披萨等。
  • NOVEL ANTIMICROBIAL COMPOUNDS
    申请人:MONASH UNIVERSITY
    公开号:US20140296177A1
    公开(公告)日:2014-10-02
    A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.
    披露了一种新型生物素蛋白连接酶(BPL)抑制剂,对包括临床重要的甲氧西林耐药金黄色葡萄球菌(MRSA)在内的多种金黄色葡萄球菌具有抗菌活性,并且是无毒的。
查看更多

同类化合物

生物素-C5-叠氮 樟磺咪芬 四氢-4-(5-羟戊基)-(3AS,4S,6AR)-1H-噻吩并[3,4-D]咪唑-2(3H)-酮 咪噻吩 利地霉素 5-硫杂-1,2A-二氮杂环戊并[Cd]并环戊二烯 1,3-二苄基-2-氧代十氢噻吩并[1',2':1,2]噻吩并[3,4-d]咪唑-5-鎓溴化物 (3AS,4S,6AR)-1,3-二苄基-2-氧代六氢-1H-噻吩并[3,4-d]咪唑-4-甲醛 (3aS,4S,6aR)-4-(5-(1-(2-hydroxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one (3aS,4S,6aR)-4-(5-(1-(3-methoxybenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one methyl (4E,Z)-6-({5-[(3aS,4S,6aR)-1,3-bis(4-methoxybenzyl)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}oxy)hex-4-enoate 1H-thieno<3,4-d>imidazol-2(3H)-one, tetrahydro-4-(5-chloropentyl)-, <3aS-(3aα,4β,6aα)>- (3aS,4Z,6aR)-5-{hexahydro-2-oxo-4H-thieno[3,4-d]imidazol-4-ylidene}pentanoic acid methyl ester (3aS,6aR)-1,3-dibenzyl-tetrahydro-1H-thieno[3,4-d]-imidazole-2(3H)-one-4-yl-pentanoic acid (3aS,4S,6aR)-4-(5-(1-(4-iodobenzyl)-1H-1,2,3-triazol-4-yl)pentyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 1-amino-17-N-(biotinylamido)-3,6,9,12,15-pentaoxaheptadecane (3aS,4S,6aR)-4-(4-isocyanatobutyl)tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 2-[1-Hydroxy-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentylidene]-5,5-dimethyl-cyclohexane-1,3-dione (3aS,4S,6aR)-4-(4-aminobut-1-yl)hexahydro-1H-thieno[3,4-d]imidazolidin-2-one hydrochloride Methyl-bisnorbiotinyl-keton 3,4-(1',3'-Dibenzyl-2'-oxoimidazolido)-2-hydroxy-thiophen 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoic acid tert-butyl 5-[({4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}carbamoyl)amino]pentanoate 1-{5-[(2,5-dioxopyrrolidin-1-yl)oxy]-5-oxopentyl}-3-{4-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]butyl}urea Trimetaphan camsylate (3aS,4S,6aR)-4-hexyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 1-Benzyl-1,3a,4,6,7,8,8a,8b-octahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium-2-olate--hydrogen chloride (1/1) (3aα,6aα)-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazole (3aα,6aβ)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (3aα,6aα)-1,3-dibenzylhexahydro-1H-thieno<3,4-d>imidazol-2(3H)-one 5,5-dioxide (E)-5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pent-2-enoic acid (3aS,4Z,6aR)-1,3-dibenzyl-4-(3-methoxypropylidene)-6,6a-dihydro-3aH-thieno[3,4-d]imidazol-2-one (3aS,6aR)-1-Isopropyl-5,5-dioxo-hexahydro-5λ6-thieno[3,4-d]imidazol-2-one (3AS-cis)-1,3-dibenzyltetrahydro-4-(3-methoxypropylidene)-1H-thieno(3,4-d)imidazol-2(3H)-one (3ar,6ac)-tetrahydro-thieno[3,4-d]imidazol-2-one 2-oxo-(3ar,3bξ,8ac)-decahydro-thieno[1',2':1,2]thieno[3,4-b]imidazolium; bromide biotin hydrazide (3aS,4S,6aR)-1,3-bis[(3-bromophenyl)methyl]-4-(5-hydroxypentyl)-3a,4,6,6a-tetrahydrothieno[3,4-d]imidazol-2-one 4-Pentyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-3-benzyl-4-pentyl-3a,4,6,6a-tetrahydro-1H-thieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-hept-6-ynyl-2-oxo-tetrahydro-thieno[3,4-d]imidazole-1,3-dicarboxylic acid di-tert-butyl ester (3aS,4S,6aR)-4-(6-hydroxyhexyl)-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one (3aS,4S,6aR)-4-oct-7-ynyl-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-2-one 6-(methyl{5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentyl}amino)hexanoic acid 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentyl dimethyl phosphite Methyl-tetranorbiotinyl-keton (2aR,7aS,7bS)-Hexahydro-2H-1-thia-3,4a-diazacyclopent[cd]inden-4(3H)-one 8-(2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)octanoic acid 2'-thiobiotinol